Historical record - last NADAC effective date: 1/1/2018
Product Information
ADVAIR 500-50 DISKUS is a brand product labeled by GlaxoSmithKline LLC, priced at $16.9172 per EA under NDC 00173069704. Its NADAC has been published 269 times since Nov 28, 2013.
FDA first approved this application on Aug 24, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500; 50 ug/1; ug/1
Manufacturer
GlaxoSmithKline LLCNDC
00173069704
Classification
Brand
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Effective Date
1/1/2018
Active Ingredients
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATEApproval Type
New Drug (NDA)
FDA Application
NDA021077FDA Approved
8/24/2000
TE Code
AB
On Market Since
3/5/2001
Pharmacological Classes
Price Statistics
The NADAC for ADVAIR 500-50 DISKUS has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 43.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.9172 per EA |
|---|---|
| All-time high | $16.9172 (Jan 16, 2019) |
| All-time low | $11.7555 (Nov 28, 2013) |
| Median price | $14.3704 |
| Average price | $14.4550 |
| Largest weekly change | +9.0% (Jan 10, 2018) |
| Weeks tracked | 269 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+43.9%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 90% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
GlaxoSmithKline LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluticasone propionate and salmeterol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ADVAIR 500-50 DISKUS?
The current National Average Drug Acquisition Cost (NADAC) for ADVAIR 500-50 DISKUS, manufactured by GlaxoSmithKline LLC, is $16.9172 per EA (NDC 00173069704), effective Jan 16, 2019.
How has the price of ADVAIR 500-50 DISKUS changed over time?
Over the history we have for it, the NADAC for ADVAIR 500-50 DISKUS has risen 43.9%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ADVAIR 500-50 DISKUS?
Since Nov 28, 2013, the NADAC for ADVAIR 500-50 DISKUS has ranged from a low of $11.7555 (Nov 28, 2013) to a high of $16.9172 (Jan 16, 2019), with a median of $14.3704 per EA.
Are there cheaper alternatives to ADVAIR 500-50 DISKUS?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUTICASONE-SALMETEROL 500-50, is $1.6362 per EA — about 90% below ADVAIR 500-50 DISKUS.
Who manufactures ADVAIR 500-50 DISKUS?
ADVAIR 500-50 DISKUS (NDC 00173069704) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.